Myosins are mechanoenzymes that interact with actin filaments and hydrolyse ATP to generate movement and force. This enables myosins to propel the sliding of actin filaments, to produce tension on actin filaments and to walk along these filaments. As a result, myosins can regulate the structure and dynamics of the actin cytoskeleton and affect the localization and transport of cellular components. The different myosins are grouped into classes on the basis of their motor domains. There are 35 known classes of myosin, and humans have 40 myosin genes that fall into 13 classes (I, II, III, V, VI, VII, IX, X, XV, XVI, XVIII, XIX and XXXV).
Myosins are actin-dependent motors that participate in a diverse range of crucial activities, including muscle contraction, intracellular trafficking, cell division, motility, actin cytoskeletal organisation and cell signaling. Myosin malfunction has been implicated in a variety of disorders including deafness, hypertrophic cardiomyopathy, Usher syndrome, Griscelli syndrome and cancer.
Myosin light chain kinase (MLCK) is an enzyme that activates the myosin light chain to exert its function related to cytoskeleton contraction and tight junction regulation. In most cells, MLCK is a transducer for signalling MLC phosphorylation in response to Ca2+ binding to MLCK-associated calmodulin. MLCK-mediated MLC phosphorylation and actomyosin contractility is important in muscle contraction, cell migration, and endo/exocytic processes, and is recognized for its central role in signalling endothelial cell-cell adhesion and barrier function.
Mavacamten(MYK461)是一种具有口服活性的心肌肌球蛋白调节剂,在牛心脏和人心脏中的 IC50 值分别为 490 nM 和 711 nM。
Mavacamten (Standard) 是 Mavacamten 的分析标准品,用于研究及分析应用,而 Mavacamten (MYK461) 是一种具有口服活性的心肌肌球蛋白调节剂,在牛心脏和人心脏中的 IC50 值分别为 490 nM 和 711 nM。
Mavacamten-d1 (MYK461-d1; SAR439152-d1) 是氘代标记的 Mavacamten (MS-M78216),而 Mavacamten (MYK461) 是一种具有口服活性的心肌肌球蛋白调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490 nM 和 711 nM。
Mavacamten-d5 (MYK461-d5; SAR439152-d5) 是氘代标记的 Mavacamten (MS-M78216),而 Mavacamten (MYK461) 是一种具有口服活性的心肌肌球蛋白调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490 和 711 nM。
Mavacamten-d6 (MYK461-d6; SAR439152-d6) 是氘代标记的 Mavacamten (MS-M78216),而 Mavacamten (MYK461) 是一种具有口服活性的心肌肌球蛋白调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490 和 711 nM。
Mavacamten-d7(MYK461-d7)是氘代标记的 Mavacamten,而 Mavacamten(MYK461)是一种具有口服活性的心肌肌球蛋白调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490 nM 和 711 nM。
Myosin modulator 1(Compound B141)是一种肌球蛋白(myosin)调节剂,可抑制兔腰大肌、猪心房和猪心室中的 ATP 酶活性,IC25 分别为 0.42、0.13 和 3.09 μM,并可调节 Sprague Dawley 大鼠的心脏收缩。
Myosin modulator 2(Compound B172)是一种肌球蛋白(myosin)调节剂,可抑制兔腰大肌、猪心房和猪心室中的 ATP 酶,IC25 分别为 2.013、2.94 和 20.93 μM,并可调节 Sprague Dawley 大鼠的心脏收缩性能。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号